Awe-inducing raves are linked to transformative experiences and social bonding, study finds
Marijuana Stocks, Finance, & InvestingUncategorized November 10, 2021
A study recently published in Frontiers provides new insight into the psychology of raves.
Read moreSenators Urge Biden To Grant Mass Pardon For Thousands Of Marijuana Cases
Marijuana Stocks, Finance, & InvestingUncategorized November 10, 2021
A group of senators is urging President Joe Biden to use his executive authority to grant a mass pardon for people with non-violent marijuana convictions, a first step toward righting the wrongs of prohibition.
Read moreMINDCURE Positioned For Strong Run In 2022 – CEO Q&A
Marijuana Stocks, Finance, & InvestingUncategorized November 9, 2021
MINDCURE’s President and CEO, Kelsey Ramsden updates investors on iSTRYM’s launch and rapid penetration, as well as drug development news on several fronts.
Read moreCybin Announces Positive CYB003 Data Demonstrating Significant Advantages Over Oral Psilocybin for Treatment of Mental Health
Marijuana Stocks, Finance, & InvestingUncategorized November 9, 2021
CYB003 is demonstrating superior treatment properties vs. an oral dosage of psilocybin.
Read moreMINDCURE’s Update Hints At Big Things To Come
Marijuana Stocks, Finance, & InvestingUncategorized November 6, 2021
As MINDCURE’s iSTRYM digital therapeutics platform rapidly gathers momentum, the company looks poised to join the emerging rally in the sector.
Read moreNovamind Reports FY2021 Financial Results and Operating Highlights
Marijuana Stocks, Finance, & InvestingUncategorized November 6, 2021
Novamind reports its full year results for fiscal 2021, including industry-leading revenue of CAD$6 million.
Read moreCongressional Lawmakers Approve Marijuana Research Bill For Veterans Despite Biden Administration Opposition
Marijuana Stocks, Finance, & Investing November 6, 2021 0
Congressional Lawmakers Approve Marijuana Research Bill For Veterans Despite Biden Administration Opposition
A House committee on Thursday approved a bill that would require the U.S. Department of Veterans Affairs to conduct clinical trials into the therapeutic potential of marijuana for military veterans.
MINDCURE Provides Update on Studies and Clinical Trials
Marijuana Stocks, Finance, & InvestingUncategorized November 4, 2021
Mind Cure Health Inc., is pleased to provide an operational progress update on the strategic initiatives of its operating segments – MINDCURE Research and MINDCURE Technology.
Read morePsilocybin-assisted psychotherapy might help to reduce attachment anxiety
Marijuana Stocks, Finance, & InvestingUncategorized November 4, 2021
Scientists have begun to examine whether the psychedelic drug psilocybin, the active component of “magic” mushrooms, can help people who feel insecure in their attachments to others.
Read moreCybin Granted DEA Schedule I Manufacturing License
Marijuana Stocks, Finance, & InvestingUncategorized November 4, 2021
Cybin announces receiving its DEA Schedule I Manufacting License, necessary to work with Schedule I controlled substances in the U.S.
Read more